Navigation Links
27-Year Pharmaceutical Marketing Leader Ruth Desmond Joins Stream57
Date:1/13/2009

NEW YORK, Jan. 13 /PRNewswire/ -- Stream57, the leading provider of fully customizable webcasting and streaming media communications, is proud to announce that pharmaceutical industry veteran Ruth Desmond has joined the company as Vice President, Healthcare, bringing nearly three decades of experience, knowledge and success to the virtual communications software company. Dr. Desmond assumed the role at the beginning of the new year.

"Stream57 is at the front of the pack and the gap is widening," Desmond said. "I started working with Stream57 several years ago from the other side of the table. I challenged them with new initiatives and aggressive timelines, and found them to be the most customer-centric and flexible vendor that I have worked with in my 27 years in the industry. They always delight clients and customers with their work, and I'm extremely grateful to be a part of such a talented team."

Dr. Desmond began her career in R&D for Eli Lilly and Company and Merck & Co., Inc., but soon took positions in strategic product planning and marketing, most recently serving as Executive Director, Global e-Marketing for Merck. Having worked with Stream57's StreamLine webcasting and media delivery platform for a variety of products and divisions, Dr. Desmond is very familiar with the advantages of using emerging technology in the pharmaceutical and medical marketing business.

"The fact that Stream57 offers project management as well as an amazing development team is key to making projects move efficiently and execute flawlessly," she continued. "If there is a need for physicians or patients, Stream57 can make it happen."

"We are thrilled to add Ruth to our team," Stream57 President Ben Chodor said. "I have the utmost respect for Dr. Desmond - her consistent industry-leading success, impeccable character and unmatched ability to foresee trends and opportunities - we couldn't design a more ideal candidate to lead our healthcare initiatives. Ruth's endorsement by way of embracing and promoting our technology was the most flattering and humbling praise to receive; we couldn't be more excited about where her influence and reputation will take us now."

Dr. Desmond joins Stream57 as the company comes off a banner year. In 2008, Stream57 nearly doubled in size, executed first-time projects for several new industries such as publishing and consumer product marketing, and received multiple awards and accolades including a prize at the Medical Marketing & Media Awards.

"One of my favorite quotes is from the great philosopher, Wayne Gretzky. I think he also played a little hockey," Desmond joked. "He said, 'I skate to where the puck is going to be, not where it is.' Right now, the puck is blazing toward multi-channel marketing and nobody does it better than Stream57."

For interviews or additional information, please contact Andrew Parker at 212-909-2550 x1020 or aparker@s57.com.

About Stream57

Stream57 is an energetic team that believes in the power of the Internet for learning, marketing and entertainment, with offices in New York and London. StreamLine 2.9.5, Stream57's cutting-edge webcast and rich media software suite, brings a new level of interactivity to online video presentations and e-learning. Recently named #745 in the Inc. 5000 List of Fastest Growing Private Companies, Stream57 was founded in 2001 by President Ben Chodor, and has provided software and services for rich media delivery, webcasting and e-learning solutions for a wide range of distinguished clients, including several Fortune 1000 corporations, charities, B2B publishers, higher education institutions and healthcare organizations. For more information on Stream57, please call 212-909-2550 or visit www.stream57.com.


'/>"/>
SOURCE Stream57
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... NY & Salt Lake City, UT (PRWEB) , ... February 05, ... ... Founder of Activz Whole-Food Nutrition , announced that the much-anticipated feature with author ... the New Really Cool Humans Amateur TV Network. , Each week, on his weekly ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... addition of micro-needling services in their Napa Valley office. The technique utilizes the ... Surgery Associates, Dr. Canales and Dr. Furnas, are part of only a select ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... H. Van Allen have signed a joint enrollment and degree completion agreement. ... toward associate and baccalaureate degrees at FHU|Dickson. , The agreement allows students ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to once again host, Swirl, A Wine Tasting Event at the La Gorce ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Wegener Polyangiitis ... Global Markets Direct,s, ,Wegener Polyangiitis - Pipeline Review, ... Polyangiitis,s therapeutic pipeline. This report provides comprehensive ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ...
(Date:2/4/2016)... 4, 2016 Frontier Pharma: Chronic Obstructive ... Innovation Chronic Obstructive Pulmonary Disease ... inflammation of the airways and lungs. Persistent breathing ... the disease one of the leading causes of ... the world. COPD is linked to cumulative exposure ...
(Date:2/4/2016)... SILVER SPRING, Md. , Feb. 4, 2016 ... Robert Califf , the FDA,s Deputy Commissioner for Medical Products ... far-reaching action plan to reassess the agency,s approach to opioid ... the epidemic, while still providing patients in pain access to ... The FDA will: , Re-examine the risk-benefit ...
Breaking Medicine Technology: